EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Inhibition of cytochrome P-450 2C9 pathways attenuated flow-mediated dilation in males but not females

Amir Akbari Fakhrabadi iD, Alexander A Buelow iD, Jacob E Matney iD, Sarah M Skillett, Jiwon Song iD, Christopher Mixon iD, Matthew D Stanford, John D Ashley iD, J Mikhail Kellawan iD

Journal of Applied Physiology · 2025

DOI: 10.1152/japplphysiol.00499.2025 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Applied Physiology, 2025. Verfasst von Amir Akbari Fakhrabadi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Circulation Research Laboratory, Department of Health and Exercise Science, University of Oklahoma, Norman, Oklahoma, United States. Hauptthemen laut MEDLINE: Vasodilation, Cytochrome P-450 CYP2C9, Fluconazole, Cytochrome P-450 CYP2C9 Inhibitors. Die Arbeit nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study demonstrates that inhibiting CYP2C9 significantly reduces brachial artery flow-mediated dilation (FMD) in young, healthy adults, implicating CYP2C9-derived metabolites as a mediator of endothelium-dependent vasodilation. Notably, CYP2C9 inhibition attenuated FMD in males, whereas females maintained their vasodilatory response, suggesting sex-specific reliance on CYP2C9 signaling. These findings enhance our understanding of sex differences in vascular regulation and may inform future strategies for preserving endothelial health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VasodilationCytochrome P-450 CYP2C9FluconazoleCytochrome P-450 CYP2C9 InhibitorsHumansMaleFemaleYoung AdultDouble-Blind MethodAdultBrachial ArteryEndothelium, VascularRegional Blood FlowSex Factors

Stichwörter der Autor:innen

cytochrome P-450 2C9endothelial-derived hyperpolarizing factorflow-mediated dilationfluconazolesex difference

Substanzen

Cytochrome P-450 CYP2C9FluconazoleCytochrome P-450 CYP2C9 InhibitorsCYP2C9 protein, human

Autor:innen und Institutionen

  • Human Circulation Research Laboratory, Department of Health and Exercise Science, University of Oklahoma, Norman, Oklahoma, United States.
  • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
  • Department of Kinesiology, Health Promotion, and Recreation, University of North Texas, Denton, Texas, United States.
  • Department of Neurology, Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, Texas, United States.

ORCID-Profile: Amir Akbari Fakhrabadi, Alexander A Buelow, Jacob E Matney, Jiwon Song, Christopher Mixon, John D Ashley, J Mikhail Kellawan

Zitieren

APA

Akbari Fakhrabadi, A., Buelow, A. A., Matney, J. E., Skillett, S. M., Song, J., Mixon, C., Stanford, M. D., Ashley, J. D., & Kellawan, J. M. (2025). Inhibition of cytochrome P-450 2C9 pathways attenuated flow-mediated dilation in males but not females. Journal of Applied Physiology. https://doi.org/10.1152/japplphysiol.00499.2025

Vancouver

Akbari Fakhrabadi A, Buelow AA, Matney JE, Skillett SM, Song J, Mixon C, et al. Inhibition of cytochrome P-450 2C9 pathways attenuated flow-mediated dilation in males but not females. Journal of Applied Physiology. 2025. doi:10.1152/japplphysiol.00499.2025

BibTeX
@article{AkbariFakhrabadi2025,
  author = {Akbari Fakhrabadi, Amir and Buelow, Alexander A and Matney, Jacob E and Skillett, Sarah M and Song, Jiwon and Mixon, Christopher and Stanford, Matthew D and Ashley, John D and Kellawan, J Mikhail},
  title = {Inhibition of cytochrome P-450 2C9 pathways attenuated flow-mediated dilation in males but not females},
  journal = {Journal of Applied Physiology},
  year = {2025},
  doi = {10.1152/japplphysiol.00499.2025}
}
Kostenlos starten →